Content :
Content :
Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare hematological disorder that primarily affects red blood cells, leading to their premature destruction and subsequent release of hemoglobin into the bloodstream.
PNH is intravascular hemolysis resulting from an attack on the immune system through the complement system. This condition is caused by a mutation in the PIG-A gene, which results in a deficiency of certain proteins responsible for protecting blood cells.
The name of the disease, "paroxysmal nocturnal hemoglobinuria", also describes its characteristics:
In addition to hemoglobinuria, people with PNH can develop thromboses and kidney damage, among other non-specific symptoms of anemia such as shortness of breath and fatigue.
Paroxysmal nocturnal hemoglobinuria is a hemolytic anemia characterized by a mutation in the X-linked PIG_A gene, which affects hematopoietic stem cells. This mutation results in the production of blood cells deficient in proteins necessary to maintain cell membrane stability, including those involved in regulating the complement system and its activation.
As a result, blood cells of the PNH become very susceptible to complement-mediated lysis, which occurs intravascularly and results in the typical manifestations of hemolytic anemia. These manifestations may also be associated with thrombocytopenia or an increased risk of thrombosis.
Hemolysis causes red blood cells to be destroyed more quickly, exceeding the body's ability to replace them, resulting in anemia. Some of the symptoms associated with anemia are listed below:
The red blood cells of people with PNH are targeted by part of the immune system which destroys them. Fragmentation of red blood cells causes symptoms of hemolysis, including
PNH can cause excess blood clots to form, although the exact reason remains unclear to doctors. However, it is the subject of intensive research, and it is suspected that the mutation in the PIG_A gene, responsible for PNH, may also alter the structure of platelets, contributing to a greater propensity for blood clotting.
General symptoms of increased blood clotting or thrombosis may include:
When the body develops widespread thromboses, it exhausts its ability to replace proteins and platelets. This drop in platelet count can lead to coagulation defects , manifested by bruising and bleeding, as follows:
Paroxysmal nocturnal hemoglobinuria is a rare disease in which red blood cells are destroyed by the immune system, including the complement system, due to a defect in the PIGA gene in stem cells bone marrow.
Symptoms include hemolytic anemia, thromboses, and kidney and liver damage.
Diagnosis is generally made by flow cytometry, and treatment is based on targeted therapy called complement inhibitors. Additional supportive treatments may also be needed.
References